Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Cash from Financing Activities (2016 - 2026)

Avanos Medical's Cash from Financing Activities history spans 13 years, with the latest figure at -$2.7 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 90.15% to -$2.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$37.0 million, a 24.64% increase, with the full-year FY2025 number at -$37.0 million, up 24.64% from a year prior.
  • Cash from Financing Activities hit -$2.7 million in Q4 2025 for Avanos Medical, down from -$2.0 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for AVNS hit a ceiling of $105.7 million in Q1 2022 and a floor of -$114.7 million in Q4 2023.
  • Historically, Cash from Financing Activities has averaged -$8.9 million across 5 years, with a median of -$10.2 million in 2021.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 52950.0% in 2022 and later plummeted 4057.14% in 2025.
  • Tracing AVNS's Cash from Financing Activities over 5 years: stood at -$25.8 million in 2021, then grew by 15.12% to -$21.9 million in 2022, then tumbled by 423.74% to -$114.7 million in 2023, then surged by 76.11% to -$27.4 million in 2024, then soared by 90.15% to -$2.7 million in 2025.
  • Business Quant data shows Cash from Financing Activities for AVNS at -$2.7 million in Q4 2025, -$2.0 million in Q3 2025, and -$3.2 million in Q2 2025.